AYTU BIOPHARMA, INC (AYTU) Form 10-K Annual Reports
AYTU BIOPHARMA, INC (AYTU) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AYTU
CIK: 1385818
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 06/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 6/30/2023 12:00:00 AM
Lead Engagement PartnerAndrew Bauer
Audit LocationDenver, Colorado, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-K | 2026-09-22 | 2026-06-30 | FORM 10-K | 0001437749-26-030908 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | FORM 8-K | 0001437749-26-030900 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000935836-26-000405 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025083 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025082 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025081 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025080 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025078 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025077 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025076 | View SEC Doc Filr Page |
| 4 | 2026-07-30 | 2026-07-28 | FORM 4 | 0001437749-26-025075 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-23 | FORM 8-K | 0001437749-26-021707 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001437749-26-016721 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | FORM 8-K | 0001437749-26-016717 | View SEC Doc Filr Page |
| 8-K | 2026-04-02 | 2026-03-31 | FORM 8-K | 0001437749-26-011116 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0000935836-26-000109 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-13 | — | SCHEDULE 13G/A Filing | 0001535264-26-000010 | View SEC Doc Filr Page |
| 10-Q | 2026-02-03 | 2025-12-31 | FORM 10-Q | 0001437749-26-002804 | View SEC Doc Filr Page |
| 8-K | 2026-02-03 | 2026-02-03 | FORM 8-K | 0001437749-26-002799 | View SEC Doc Filr Page |
| 8-K | 2026-01-20 | 2026-01-20 | FORM 8-K | 0001437749-26-001543 | View SEC Doc Filr Page |
| 8-K | 2025-12-10 | 2025-12-10 | FORM 8-K | 0001437749-25-037389 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-14 | — | SCHEDULE 13G/A Filing | 0000935836-25-000682 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | FORM 10-Q | 0001437749-25-034825 | View SEC Doc Filr Page |
| 8-K | 2025-11-13 | 2025-11-13 | FORM 8-K | 0001437749-25-034822 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-11-12 | — | SCHEDULE 13G/A Filing | 0001193805-25-001566 | View SEC Doc Filr Page |